Suvorexant Recruiting Phase 4 Trials for Insomnia Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02729714A Pilot Study of Suvorexant for Insomnia in Parkinson Disease